Skip to main content
. 2022 Apr 13;29(1):1243–1256. doi: 10.1080/10717544.2022.2063454

Figure 8.

Figure 8.

In vivo therapeutic efficacy. (A) Tumor growth curve of the KYSE150 tumor xenograft model (n = 6). Mice were treated with Fv-LDP-D3-AE (0.2 mg/kg). (B) Body weight growth curve of ESCC KYSE150 tumor xenograft models. KYSE520 xenograft mice were treated with various doses of Fv-LDP-D3 (20, 40 mg/kg), Fv-LDP-D3-AE (0.25, 0.50 mg/kg). (C) Tumor growth curves. (D) Tumor weights at the end of the experiment. (E) Body weight change curves, and (F) Immunohistochemical detection of Ki-67. *p < 0.05, **p < 0.01, ***p < 0.001 compared with the control.